Improved Health Outcomes in Patients with Systemic Lupus Erythematosus Following Early Belimumab Initiation Without Prior Immunosuppressant Use: A Real-World Descriptive Study.
Bernard RubinYan ChenKaren WorleyBrendan RabideauBenson WuRose ChangMaral DerSarkissianPublished in: Rheumatology and therapy (2024)
These results suggest that patients initiating BEL before versus after immunosuppressant use had more favorable outcomes.